Ashfield Capital Partners, LLC Novartis Ag Transaction History

Ashfield Capital Partners, LLC

$1.19 Billion
Q3 2022

A detailed history of Ashfield Capital Partners, LLC transactions in Novartis Ag stock. As of the latest transaction made, Ashfield Capital Partners, LLC holds 4,727 shares of NVS stock, worth $464,900. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,727

Previous 4,727 -0.0%

Holding current value

$464,900

Previous $400,000 10.25%

% of portfolio

0.03%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$80.52 - $93.75 $11,836 - $13,781	-147 Reduced 3.02%	4,727 $400,000
Q4 2021 Feb 02, 2022	BUY	$79.7 - $88.13 $1,992 - $2,203	25 Added 0.52%	4,874 $426,000
Q3 2021 Nov 09, 2021	SELL	$81.78 - $95.14 $29,359 - $34,155	-359 Reduced 6.89%	4,849 $397,000
Q2 2021 Aug 09, 2021	SELL	$85.24 - $94.15 $127,092 - $140,377	-1,491 Reduced 22.26%	5,208 $475,000
Q4 2020 Feb 02, 2021	SELL	$78.07 - $94.43 $3,513 - $4,249	-45 Reduced 0.67%	6,699 $633,000
Q3 2020 Nov 03, 2020	SELL	$82.14 - $91.0 $24,067 - $26,663	-293 Reduced 4.16%	6,744 $586,000
Q2 2020 Aug 05, 2020	SELL	$80.93 - $91.1 $270,791 - $304,820	-3,346 Reduced 32.23%	7,037 $615,000
Q1 2020 May 06, 2020	SELL	$70.67 - $99.01 $38,161 - $53,465	-540 Reduced 4.94%	10,383 $856,000
Q4 2019 Feb 07, 2020	SELL	$84.35 - $95.37 $47,236 - $53,407	-560 Reduced 4.88%	10,923 $1.03 Million
Q2 2019 Jul 29, 2019	SELL	$75.4 - $92.8 $134,287 - $165,276	-1,781 Reduced 13.43%	11,483 $1.05 Million
Q1 2019 Apr 30, 2019	SELL	$75.32 - $86.15 $80,893 - $92,525	-1,074 Reduced 7.49%	13,264 $1.28 Million
Q4 2018 Feb 13, 2019	SELL	$73.66 - $82.02 $95,610 - $106,461	-1,298 Reduced 8.3%	14,338 $1.23 Million
Q3 2018 Nov 02, 2018	SELL	$66.94 - $77.43 $528,692 - $611,542	-7,898 Reduced 33.56%	15,636 $1.35 Million
Q2 2018 Jul 26, 2018	SELL	$64.91 - $73.36 $5,647 - $6,382	-87 Reduced 0.37%	23,534 $1.78 Million
Q1 2018 May 02, 2018	BUY	$70.39 - $84.15 $441,134 - $527,368	6,267 Added 36.11%	23,621 $1.91 Million
Q4 2017 Feb 13, 2018	BUY	$72.33 - $77.64 $165,491 - $177,640	2,288 Added 15.19%	17,354 $1.46 Million
Q3 2017 Nov 07, 2017	SELL	$74.14 - $77.27 $444 - $463	-6 Reduced 0.04%	15,066 $1.29 Million
Q2 2017 Aug 14, 2017	BUY	N/A	15,072	15,072 $1.26 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashfield Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ashfield Capital Partners, LLC with notifications on news.

Account

Ashfield Capital Partners, LLC Novartis Ag Transaction History